5% stakes
Affinity Asset Advisors
Institution
- 5% stake reports
- 19
- 5% stake stocks
- 12
- Latest report
- 26/08/13
5% stake reports
| Stock | ||
|---|---|---|
| Lexeo Therapeutics LXEO08/13 | 8.4%6,674,913 sh | +1.3pp |
| Equillium EQ08/13 | 6.5%4,100,000 sh | First report |
| Amanat Acquisition AMAN08/13 | 5%375,000 sh | First report |
| First Tracks Biotherapeutics TRAX08/13 | 5.8%2,032,012 sh | First report |
| Ovid Therapeutics OVID08/13 | 7.9%15,143,728 sh | −1.2pp |
| NextCure NXTC08/13 | 6.4%274,073 sh | −3.6pp |
| Sutro Biopharma STRO05/14 | 6.5%1,069,519 sh | −2.3pp |
| Helix Acquisition Corp. III HLXC05/14 | 7%1,250,000 sh | First report |
| NextCure NXTC01/29 | 9.99%348,607 sh | +2.8pp |
| Sutro Biopharma STRO01/29 | 8.8%748,382 sh | +1.0pp |
| Avalo Therapeutics AVTX01/29 | 5.7%1,051,054 sh | −1.9pp |
| Ovid Therapeutics OVID25/12/18 | 9%12,149,166 sh | First report |
| Verrica Pharmaceuticals VRCA25/12/03 | 5.47%884,172 sh | First report |
| Avalo Therapeutics AVTX25/11/13 | 7.65%1,006,217 sh | +2.4pp |
| Sutro Biopharma STRO25/10/23 | 7.77%6,583,772 sh | First report |
| iBio25/08/26 | 9.99%4,280,000 sh | First report |
| Lexeo Therapeutics LXEO25/06/04 | 7.75%4,252,005 sh | First report |
| Karyopharm Therapeutics KPTI25/04/10 | 7.83%664,224 sh | First report |
| Avalo Therapeutics AVTX24/12/31 | 5.3%550,765 sh | First report |
